Clinical Trials

About Clinical Trials

Clinical Trials

Investigators Meeting

Interesting Articles

More >>


More >>

Clinical Trials N003

Randomized Trial of Docetaxel (T) with or without Capecitabine (X) as Neoadjuvant Chemotherapy in Female Patients with Operable Breast Cancer Who were not Observed Disease Progression after 4 cycles of 5-Fluorouracil, Epirubicin and Cyclosphamide (FEC)

Study Duration: Nov. 2005 - Dec. 2014
Principal Investigators: Prof. Masakazu Toi (President of OOTR, Kyoto University), Dr. Shiniji ohno (Director of OOTR, Kyusyu Cancer Center), Dr. Louis W.C. Chow (Executive Director of OOTR)
Participating Institutes: 16 (as of 30th April, 2009)
Target: 500 cases
Registration: Closed
e-mail: and English)


Please apply Membership

Enrollment Privilege

Discount for Institution Annual Conference Registration

Free subscription - OOTR partner mags IJBM